Optum Health lifted patient-facing hours 12% to steady its Medicare business

UnitedHealth Group's 2025 opened with disastrous results — shares tumbled after the first quarter, and its care-delivery unit Optum Health was a major contributor. Care activity had spiked, particularly in the Medicare population, weighing on both Optum and the UnitedHealthcare Medicare Advantage book.

At the Wells Fargo Healthcare Conference in September 2026, Optum Health CEO Krista Nelson laid out what the unit has done since. New programs launched in response to the downturn drove improved clinical performance around transitions of care, care coordination and patient support — visible in skilled nursing facility admissions, inpatient readmissions and length of stay. 'All of our clinical metrics are really performing better than we expected,' she said; UnitedHealth's Q2 results had already spotlighted the turnaround in Medicare Advantage.

Cost management became 'a really big theme' for 2026: Optum grew patient-facing hours by 12% in the first half of the year — about 200,000 hours — while pushing physician productivity and scheduling updates. The unit also dug into its other payer contracts to find misalignment, and says the vast majority of addressable contracts for 2027 have been managed.

Structural moves continue alongside: Optum plans to sell its interest in certain Florida clinics to private equity firm TPG, keeping a partner for growth rather than exiting the state. Nelson said performance is pacing ahead of schedule, supporting investment in late 2026 and margin expansion 'by points' in 2027 and 2028 — though top-line growth will not be next year's focus.

Patient-facing hours up 12% (about 200,000 hours) in H1 2026; clinical metrics beating expectations; margin expansion projected for 2027–28.

Care activity that outruns a capitated revenue model turns volume growth into losses, so the levers have to be clinical utilization, not just price.

More patient-facing hours attack the problem at its source: earlier intervention shows up in readmissions, length of stay and nursing-facility use.

Payer contracts priced on pre-spike assumptions leave the unit carrying misaligned risk; repricing the 2027 book caps the downside.

Selling clinic stakes to a growth-oriented partner raises cash and focus without abandoning the market.

When utilization spikes wreck a risk-bearing book, the fix is operational, not financial: more clinical hours, tighter scheduling, and repricing every payer contract that no longer matches the risk.

The turnaround was still in progress as of September 2026: clinical metrics ahead of plan, payer contract work largely done for 2027, margin expansion guided for 2027–28 and the TPG clinic stake sale pending. No full-year 2026 figures are given in the source.